Literature DB >> 8281537

Doppler echocardiographic assessment of left ventricular diastolic function in patients with progressive systemic sclerosis.

S Fujimoto1, T Kagoshima, T Nakajima, K Dohi.   

Abstract

To investigate the diastolic function of the left ventricle in patients with progressive systemic sclerosis (PSS), 13 patients with PSS (3 males and 10 females; group PSS) were examined by Doppler echocardiography. As a control 8 age-matched healthy volunteers (3 males and 5 females; group H) were also examined. Pulse-wave transmitral Doppler flow velocity curves were digitized and curves of the first derivatives were obtained. In group PSS, total left ventricular wall thickness and left atrial dimension were increased, the ratio between the left ventricular end-diastolic dimension and the left ventricular wall thickness was decreased, late peak diastolic filling was increased, isovolumic relaxation time was prolonged, compared with group H. The patients with left ventricular wall thickening out of proportion to left ventricular end-diastolic dimension had decreased early peak diastolic filling. We conclude that patients with PSS have deterioration of left ventricular diastolic function, and the diastolic function is severely disturbed in patients with left ventricular wall thickening out of proportion to left ventricular end-diastolic dimensions.

Entities:  

Mesh:

Year:  1993        PMID: 8281537     DOI: 10.1159/000175973

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Cardiac manifestations in primary Sjögren's syndrome.

Authors:  M Gyöngyösi; G Pokorny; Z Jambrik; L Kovács; A Kovács; E Makula; M Csanády
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

2.  Serum levels of tissue inhibitors of metalloproteinase 2 in patients with systemic sclerosis with duration more than 2 years: correlation with cardiac and pulmonary abnormalities.

Authors:  Amira Shahin; Amani Elsawaf; Shahira Ramadan; Olfat Shaker; Mona Amin; Mohamed Taha
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.